Madelaine Ryan is a Plattsburgh, New York based nurse practitioner. Active license number of Madelaine Ryan is 352040F for Acute Care in New York. Her current practice location is 75 Beekman St, Plattsburgh. Patients can reach her at 518-567-7482 or can fax her at 518-562-7118. Madelaine Ryan is NP and her NPI number (Unique professional ID assigned by NPPES) is 1649963182. Madelaine Ryan has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Madelaine Ryan speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1649963182
NPI Enumeration Date:
31 May, 2023
NPI Last Update On:
26 Oct, 2023
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Madelaine Ryan are as mentioned below.
License Number
Specialization
State
Status
352040F
Acute Care
New York
Primary
672944
Registered Nurse
New York
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Madelaine Ryan 2 Sarachon Rd, Chazy, New York
Zip:
12921-2322
Patients can reach Madelaine Ryan at 75 Beekman St, Plattsburgh, New York or can call to book an appointment on 518-567-7482.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 January, 2025.